Windtree Therapeutics

Last updated: June 14, 2024

Craig Fraser - CEO
Craig Fraser - CEO
USA | Funding: $140.4M (+)

Website: https://www.windtreetx.com/

Windtree is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.